• Home
• About New York Injury News
• New York Lawyer Panel
• New Jersey Injury Lawyers
• Long Island Personal Injury Lawyers
• Ask A Lawyer
• News Tags

• Construction Accidents
• Injury News
• Medical Malpractice
• Motor Vehicle Accidents
• Personal Injury Accidents
• Premises Liability
• Product Liability
• Work Related Fire Fighter Deaths
• Wrongful Death

FDA requires black box warning-Reglan may cause permanent injury!

New York, NY (NewYorkInjuryNews.com)–The U.S. Food and Drug Administration (FDA) www.fda.gov announced drug makers are now required to place a black box warning on all metoclopramide containing drugs like Reglan. Federal regulators must warn patients, healthcare professionals and medication consumers about the risk of serious injury in long-term or high-dose use of all metoclopramide containing drugs.

Metoclopramide has been linked to tardive dyskinesia a rarely curable condition which causes constant involuntary repetitive movements of the extremities, or lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers. Tardive dyskinesia is a chronic medical condition patients continue to suffer even after discontinuation of the harmful medication. These symptoms are rarely reversible and there is no known treatment. Reglan and other metoclopramide containing drugs are used to treat gastroesophageal reflux disease (GERD) and gastroparesis. Both medical conditions are chronic and incurable. The only successful treatment by doctors and nurses is symptom management. Recently published studies reveal metoclopramide is the most common cause of drug-induced movement disorders.

Metoclopramide containing medications are approved by the FDA for short term use no longer than 12 weeks maximum. Civil trial lawyers across the country specializing in product liability claims involving drug injury cases are in the process of investigating and filing claims against many metoclopramide drug companies. The product liability attorneys are alleging drug makers used deceptive marketing practices and misleading medication labeling for doctors to repeatedly prescribe the medications to patients suffering with the chronic gastrointestinal orders. This has caused many patients to take the medication for longer than the approved short term treatment, and at much higher doses, leading to cases of irreversible tardive dyskinesia.

NewYorkInjuryNews.com powered by New York Defective products lawyers

Related posts

• New York road accident shatters dreams of a young girl (0)
• Motorcycle accident injury news, New York teacher dies in motorcycle crash (0)
• Quick approval is not always a good thing (0)
• Truck runs red light, kills three (0)
• Knowing Your Rights - The Statute of Limitations for Medical Negligence (0)
• Landowners’ Liability under New York Law for Conditions on their Property (0)
• Food Poisoning and Food Products Liability Claims (0)
• Municipalities Can Be Held Liable When They Act Like Private Companies (0)
• Bank of America settles $75 million Merrill Lynch employee lawsuit (0)
• FDA alerts healthcare workers-topical pain meds before mammograms (0)